 |
|
Treatment of Drug Susceptible Pulmonary Tuberculosis
Hong-Joon Shin, Yong-Soo Kwon
Tuberc Respir Dis. 2015;78(3):161-167. Published online 2015 Jun 30 DOI: https://doi.org/10.4046/trd.2015.78.3.161
|
|
Citations to this article as recorded by
 Development of a population pharmacokinetic model of pyrazinamide to guide personalized therapy: impacts of geriatric and diabetes mellitus on clearance
Ryunha Kim, Rannissa Puspita Jayanti, Hongyeul Lee, Hyun-Kuk Kim, Jiyeon Kang, I-Nae Park, Jehun Kim, Jee Youn Oh, Hyung Woo Kim, Heayon Lee, Jong-Lyul Ghim, Sangzin Ahn, Nguyen Phuoc Long, Yong-Soon Cho, Jae-Gook Shin, On behalf of the cPMTb
Frontiers in Pharmacology.2023;[Epub] CrossRef Population pharmacokinetics analyses of rifampicin in adult and children populations: A systematic review
Mohd Rahimi Muda, Sabariah Noor Harun, Syed Azhar Syed Sulaiman, Siti Maisharah Sheikh Ghadzi
British Journal of Clinical Pharmacology.2022; 88(7): 3132. CrossRef Using TBAg/PHA Ratio for Monitoring TB Treatment: A Prospective Multicenter Study
Xiaochen Wang, Mingwu Li, Guobiao Liu, Xiaoying Wu, Rong Wan, Hongyan Hou, Shiji Wu, Ziyong Sun, Haobin Kuang, Feng Wang
Journal of Clinical Medicine.2022; 11(13): 3780. CrossRef Oral Anti-Tuberculosis Drugs: An Urgent Medication Reconciliation at Hospitals in Indonesia
Fauna Herawati, Eka Yuliantini Fahmi, Noer Aulia Pratiwi, Dewi Ramdani, Abdul Kadir Jaelani, Rika Yulia, Retnosari Andrajati
Journal of Public Health Research.2021; 10(3): jphr.2021.1896. CrossRef
Nitric Oxide-Dependent Electron Transport Chain Inhibition by the Cytochrome
bc
1
Inhibitor and Pretomanid Combination Kills
Mycobacterium tuberculosis
Sheng Zeng, Jingran Zhang, Mingwei Sun, Xiaofei Zhang, Gregory M. Cook, Tianyu Zhang
Antimicrobial Agents and Chemotherapy.2021;[Epub] CrossRef Recent Advances in Drug Susceptible Pulmonary Tuberculosis Diagnosis and Treatment
Jiwon Lyu, Tae Sun Shim
The Korean Journal of Medicine.2021; 96(5): 390. CrossRef
The potassium transporter KdpA affects persister formation by regulating ATP levels in
Mycobacterium marinum
Xiaofan Liu, Chuan Wang, Bo Yan, Liangdong Lyu, Howard E. Takiff, Qian Gao
Emerging Microbes & Infections.2020; 9(1): 129. CrossRef Changes in chest X-ray findings in 1- and 2-month group after treatment initiation for suspected pulmonary tuberculosis
Jang Ho Lee, Ock-Hwa Kim, Yeon Joo Kim, Tae Sun Shim, Kyung-Wook Jo
The Korean Journal of Internal Medicine.2020; 35(5): 1145. CrossRef Multidrug-resistant tuberculosis risk factors assessment with intuitionistic fuzzy cognitive maps
Elif Dogu, Y. Esra Albayrak, Esin Tuncay, Cengiz Kahraman
Journal of Intelligent & Fuzzy Systems.2020; 38(1): 1083. CrossRef A population approach of rifampicin pharmacogenetics and pharmacokinetics in Mexican patients with tuberculosis
Susanna Edith Medellin-Garibay, Ana Patricia Huerta-García, Ana Socorro Rodríguez-Báez, Martín Magaña-Aquino, Arturo Ortiz-Álvarez, Diana Patricia Portales-Pérez, Rosa del Carmen Milán-Segovia, Silvia Romano-Moreno
Tuberculosis.2020; 124: 101982. CrossRef Early Discontinuation of Ethambutol in Pulmonary Tuberculosis Treatment Based on Results of the GenoType MTBDRplus Assay: a Prospective, Multicenter, Noninferiority Randomized Trial in South Korea
Kyung-Wook Jo, Mihye Kim, Ye-Jee Kim, Hyun-Kyung Lee, Hyun Kuk Kim, Doosoo Jeon, Jiwon Lyu, Hye Kyeong Park, Jeongha Mok, Ju Sang Kim, Eun Young Heo, Sang Bong Choi, Jae-Joon Yim, Tae Sun Shim
Antimicrobial Agents and Chemotherapy.2019;[Epub] CrossRef Impact of the change in the antitubercular regimen from three to four drugs on cure and frequency of adverse reactions in tuberculosis patients from Brazil: A retrospective cohort study
María B. Arriaga, Ninfa M. C. Torres, Nelia C. N. Araujo, Simone C. C. Caldas, Bruno B. Andrade, Eduardo M. Netto, Christophe Sola
PLOS ONE.2019; 14(12): e0227101. CrossRef Inhibitors of energy metabolism interfere with antibiotic-induced death in mycobacteria
Bei Shi Lee, Nitin P. Kalia, Xin Er F. Jin, Erik J. Hasenoehrl, Michael Berney, Kevin Pethe
Journal of Biological Chemistry.2019; 294(6): 1936. CrossRef Association of FAM65B, AGBL4, and CUX2 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity
Hongqiu Pan, Miaomiao Yang, Lihuan Lu, Bilin Tao, Xiaomin He, Hongbo Chen, Honggang Yi, Shaowen Tang
Pharmacogenetics and Genomics.2019; 29(4): 84. CrossRef Molecular drug resistance profiles of Mycobacterium tuberculosis from sputum specimens using ion semiconductor sequencing
Joonhong Park, Woori Jang, Myungshin Kim, Yonggoo Kim, So Youn Shin, Kuhn Park, Myung Sook Kim, Soyoung Shin
Journal of Microbiological Methods.2018; 145: 1. CrossRef New Players in Immunity to Tuberculosis: The Host Microbiome, Lung Epithelium, and Innate Immune Cells
Nancy Gupta, Rakesh Kumar, Babita Agrawal
Frontiers in Immunology.2018;[Epub] CrossRef Antimicrobial peptides as an alternative to anti-tuberculosis drugs
Manaf AlMatar, Essam A. Makky, Gülfer Yakıcı, Işıl Var, Begüm Kayar, Fatih Köksal
Pharmacological Research.2018; 128: 288. CrossRef Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: Emerging need for novel drug delivery approaches
Kamal Dua, Vamshi Krishna Rapalli, Shakti Dhar Shukla, Gautam Singhvi, Madhur D. Shastri, Dinesh Kumar Chellappan, Saurabh Satija, Meenu Mehta, Monica Gulati, Terezinha De Jesus Andreoli Pinto, Gaurav Gupta, Philip M. Hansbro
Biomedicine & Pharmacotherapy.2018; 107: 1218. CrossRef Recommendations for Optimizing Tuberculosis Treatment: Therapeutic Drug Monitoring, Pharmacogenetics, and Nutritional Status Considerations
Rihwa Choi, Byeong-Ho Jeong, Won-Jung Koh, Soo-Youn Lee
Annals of Laboratory Medicine.2017; 37(2): 97. CrossRef Estimated rates of recurrence, cure, and treatment abandonment in patients with pulmonary tuberculosis treated with a four-drug fixed-dose combination regimen at a tertiary health care facility in the city of Rio de Janeiro, Brazil
Vangie Dias da Silva, Fernanda Carvalho de Queiroz Mello, Sonia Catarina de Abreu Figueiredo
Jornal Brasileiro de Pneumologia.2017; 43(2): 113. CrossRef Clinical significance of smear positivity for acid-fast bacilli after ≥5 months of treatment in patients with drug-susceptible pulmonary tuberculosis
Hyung Koo Kang, Byeong-Ho Jeong, Hyun Lee, Hye Yun Park, Kyeongman Jeon, Hee Jae Huh, Chang-Seok Ki, Nam Yong Lee, Won-Jung Koh
Medicine.2016; 95(31): e4540. CrossRef Active transforming growth factor-β is associated with phenotypic changes in granulomas after drug treatment in pulmonary tuberculosis
Robert M. DiFazio, Joshua T. Mattila, Edwin C. Klein, Lauren R. Cirrincione, Mondraya Howard, Eileen A. Wong, JoAnne L. Flynn
Fibrogenesis & Tissue Repair.2016;[Epub] CrossRef
|